Free Trial

Context Therapeutics (CNTX) Earnings Date, Estimates & Call Transcripts

Context Therapeutics logo
$1.02 -0.07 (-6.42%)
(As of 12/20/2024 05:51 PM ET)

Context Therapeutics Latest Earnings Summary

Actual EPS
(Nov. 6)
-$0.22 Missed By -$0.11
Consensus EPS
(Nov. 6)
-$0.11

Context Therapeutics posted Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.22, which missed the consensus estimate of -$0.11 by $0.11. With a trailing EPS of -$0.91, Context Therapeutics' earnings are expected to grow next year, from ($0.51) to ($0.31) per share.

Get Context Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Context Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CNTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CNTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Context Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.23-$0.23-$0.23
Q2 20241-$0.27-$0.27-$0.27
Q3 20242-$0.28-$0.16-$0.22
Q4 20242-$0.31-$0.04-$0.18
FY 20246($1.09)($0.70)($0.90)

Context Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024--$0.11-$0.22 -$0.11-$0.22--
8/7/2024--$0.08-$0.04+$0.04-$0.04--
5/8/2024Q1 2024-$0.38-$0.23+$0.15-$0.23--
3/21/2024Q4 2023-$0.35-$0.42 -$0.07-$0.42--
11/9/2023Q3 2023-$0.30-$0.37 -$0.07-$0.37--
8/9/2023Q2 2023-$0.20-$0.31 -$0.11-$0.31--
5/10/2023Q1 2023-$0.19-$0.40 -$0.21-$0.40--
3/22/2023Q4 2022-$0.30-$0.22+$0.08-$0.22--

Context Therapeutics Earnings - Frequently Asked Questions

Context Therapeutics (NASDAQ:CNTX) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on CNTX's earnings history.

In the previous quarter, Context Therapeutics (NASDAQ:CNTX) missed the analysts' consensus estimate of ($0.11) by $0.11 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. CNTX's actual earnings.

Context Therapeutics (NASDAQ:CNTX) has a recorded net income of -$23.96 million. CNTX has generated -$0.91 earnings per share over the last four quarters.

Context Therapeutics's earnings are expected to grow from ($0.51) per share to ($0.31) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CNTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners